Potential role of immunological factors in early diagnosis of cancer cachexia in C26 tumor-bearing mice

Fearon KC, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16:153–166

Evans WJ, Morley JE, Argiles J et al (2008) Cachexia: a new definition. Clin Nutr 27:793–799

Tisdale MJ (1999) Wasting in cancer. J Nutr 129:243S–246S

Fearon K, Strasser F, Anker SD et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–495

Vaughan VC, Martin P, Lewandowski PA (2013) Cancer cachexia: impact, mechanisms and emerging treatments. J Cachexia Sarcopenia Muscle 4:95–109

Argiles JM, Lopez-Soriano FJ, Toledo M et al (2011) The cachexia score (CASCO): a new tool for staging cachectic cancer patients. J Cachexia Sarcopenia Muscle 2:87–93

Fogelman DR, Morris J, Xiao L et al (2017) A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients. Support Care Cancer 25:1809–1817

Taksande BG, Gawande DY, Chopde CT et al (2017) Agmatine ameliorates adjuvant induced arthritis and inflammatory cachexia in rats. Biomed Pharmacother 86:271–278

Muscaritoli M, Bossola M, Aversa Z et al (2006) Prevention and treatment of cancer cachexia: new insights into an old problem. Eur J Cancer 42:31–41

Evans C, Dalgleish AG, Kumar D (2006) Review article: immune suppression and colorectal cancer. Aliment Pharmacol Ther 24:1163–1177

Pardoll DM (2012) The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12:252–264

Ayeka PA, Bian Y, Githaiga PM et al (2017) The immunomodulatory activities of licorice polysaccharides (Glycyrrhiza uralensis Fisch.) in CT 26 tumor-bearing mice. BMC Complement Altern Med 17:536

Coelho MA, de Carne Trecesson S, Rana S et al (2017) Oncogenic RAS signaling promotes tumor Immunoresistance by stabilizing PD-L1 mRNA. Immunity 47(1083–1099):e1086

Tanaka Y, Eda H, Tanaka T et al (1990) Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res 50:2290–2295

Teunissen SC, Wesker W, Kruitwagen C et al (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manag 34:94–104

Ross PJ, Ashley S, Norton A et al (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90:1905–1911

Porporato PE (2016) Understanding cachexia as a cancer metabolism syndrome. Oncogenesis 5:e200

Bruggeman AR, Kamal AH, LeBlanc TW et al (2016) Cancer cachexia: beyond weight loss. J Oncol Pract 12:1163–1171

Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12:253–268

Aulino P, Berardi E, Cardillo VM et al (2010) Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse. BMC Cancer 10:363

Bonetto A, Rupert JE, Barreto R et al (2016) The colon-26 carcinoma tumor-bearing mouse as a model for the study of cancer cachexia. J Vis Exp 117:e54893. https://doi.org/10.3791/54893

Bronte V, Pittet MJ (2013) The spleen in local and systemic regulation of immunity. Immunity 39:806–818

DuPre SA, Hunter KW Jr (2007) Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors. Exp Mol Pathol 82:12–24

Gui J, Mustachio LM, Su DM et al (2012) Thymus size and age-related thymic involution: early programming, sexual dimorphism, progenitors and stroma. Aging Dis 3:280–290

Itoh S, Ohno T, Kakizaki S et al (2011) Epstein–Barr virus-positive T-cell lymphoma cells having chromosome 22q11.2 deletion: an autopsy report of DiGeorge syndrome. Hum Pathol 42:2037–2041

Wang Z, Zhao C, Moya R et al (2008) A novel role for CD4+ T cells in the control of cachexia. J Immunol 181:4676–4684

Camargo RG, Riccardi DM, Ribeiro HQ et al (2015) NF-kappaBp65 and expression of its pro-inflammatory target genes are upregulated in the subcutaneous adipose tissue of cachectic cancer patients. Nutrients 7:4465–4479

Morley JE, Thomas DR, Wilson MM (2006) Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr 83:735–743

Talbert EE, Lewis HL, Farren MR et al (2018) Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naive pancreatic cancer patients. J Cachexia Sarcopenia Muscle. https://doi.org/10.1002/jcsm.12251